Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma

Blood. 2008 Nov 1;112(9):3914-5. doi: 10.1182/blood-2008-07-168823.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter

MeSH terms

  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Multiple Myeloma / therapy*
  • Risk Factors
  • Stem Cell Transplantation*
  • Transplantation Conditioning
  • Transplantation, Autologous
  • Transplantation, Homologous